Amr Abbas, MD, MSc
@amrabbasmd
Followers
894
Following
2K
Media
20
Statuses
223
We have an opening for structural heart fellowship starting 07/2026. If you would like to be a part of a high volume TAVR, mitral and tricuspid TEER, Evoque TTVR, PVL/PFO/ASD closures, LAAO, ASA center and much more. Please DM me @crfheart @ACCinTouch
4
0
4
No impact of post TAVR Gradient on HVD @ 5 Years in our analysis. The change, rather than single level hemodynamics, is what matters. https://t.co/PW92RLm65b
@ThomPilgrim @BeaumontCards @AhmadJabri8 @BrianRenard1 @CorewellHealth @IvanHansonMD
@TCTMD
0
8
33
Another great @CictTherapy led by @IssamDMoussa1 with @amrmohsen213 and @DrAFrangieh excellent topics and world class faculty. Looking forward to next year @BeaumontCards @CorewellHealth
5
2
36
Discordance extends to TAV in TAV. @BeaumontCards @CorewellHealth @LuaiMadanat @AhmadJabri8 @BrianRenard1 @IvanHansonMD @JordanLuli check out our paper in JACC Asia
📉 In failed #TAVR valves, echo & invasive gradients align. But after TAV-in-TAV? 🧪 Invasive gradients are consistently lower than both post-procedure & discharge echo gradients ➡️ Are we overestimating gradients with echo? 📎 https://t.co/kJw6nmps7x
#JACCAsia #cvEcho
1
3
20
Another great #NYValves2025 meeting, Proud to be a part of this innovative cutting edge meeting @crfheart @BeaumontCards @CorewellHealth with the amazing @hahn_rt @SachinGoelMD @amrmohsen213
3
4
58
Corewell Health West and East In the Big Apple @BeaumontCards @CorewellHealth
0
0
14
Our analysis from the TVT registry for MVIV outcomes, @BeaumontCards @CorewellHealth @crfheart @JACCJournals
3 year outcomes of mitral valve in valve in the US TVT Registry: best outcomes in low and intermediate STS patients and in elective procedures; early identification important!
0
2
9
After 2 years of hard work, finally graduation is here. Masters of Science in Clinical Operations, Executive Leadership Track, Harvard Medical School @Harvard @CorewellHealth @BeaumontCards @harvardmed
11
1
61
PVL after TAVI, even mild may not be benign. @PCRonline #europcr great meeting and discussion
0
5
37
Once again discordance between echo and Cath gradients noted. This time after TAV in TAV. Check out our new paper @crfheart @CorewellHealth @BeaumontCards @hahn_rt @PPibarot @kalazizimd @IvanHansonMD @AhmadJabri8
https://t.co/beoFSshRwO
0
5
19
Do you want hands-on training in rotational atherectomy, orbital atherectomy, angio-FFR, and more… using simulators and wet models? Then CICT is for you! Join the hands-on training for fellows – limited spots remaining!
2
6
11
Great meeting @CRT_meeting 2025. Paneling with @kalazizimd @MayraGuerreroMD late breaking EFS in structural session. Proud to be a part of this innovative meeting. @CorewellHealth @BeaumontCards
1
3
23
20 years to the date. Miss those days, I am the interventional fellow with the flowery head cap in the pic, that got access :) @CorewellHealth @BeaumontCards proud to be there and proud to have had @MayraGuerreroMD as my co fellow :) and working with @HanzelGeorge @BillONeillMD
Exactly 20 years ago, the 1st TAVR in the US was done by Dr William O’Neill at William Beaumont Hospital! Dr. Alain Cribier was the proctor. I was an interventional fellow watching from the control room. Those 5 seconds when I saw the valve being deployed, literally changed my
3
6
47
Our recent paper confirming our previous findings from the TVT registry, no difference in outcomes between small and large annuli in the PARTNER trials @HoumanKhalili @IvanHansonMD @BrianRenard1 @CorewellHealth @BeaumontCards @AhmadJabri8 @MarvinEng3
This #JACCINT analysis of the combined PARTNER2 & PARTNER3 trials included 1,355 patients undergoing #TAVI & demonstrated excellent & comparable outcomes at 5yrs between patients w/ small vs large aortic annuli https://t.co/jWFNnOLE0K
#TAVR @hahn_rt @MartyBLeon @PPibarot @djc795
0
1
15
New and important journal for valve diseases under the leadership of @PPibarot, proud to be on the editorial board. Great space to share research and innovation in the field. @BeaumontCards @CorewellHealth @HoumanKhalili @kalazizimd @OUWB @IvanHansonMD @BrianRenard1 @AhmadJabri8
🥊Just published in the first issue of #JHVS: Which is the best modality to assess bioprosthetic valve hemodynamic function and adjudicate valve dysfunction following transcatheter aortic valve replacement: Doppler echocardiography or invasive assessment by cardiac
1
4
22
Debating @AdamGreenbaumMD on hemodynamics, moderated by @drnvanmieghem and great commentary by @mirvatalasnag Adam is a natural in these, lots of fun #jimgise2025 @CorewellHealth @BeaumontCards
Exciting session and debate on TAVR controversies: the first cut is the deepest lead by @drnvanmieghem and @AdamGreenbaumMD in Rome at #jimgise2025 @CurioJonathan @Sticchi_Alex @giuliamasiero3 @AliceBen_90
3
4
29
Amazing cases today presented at the JIMGISE2025 in Rome, by @drnvanmieghem and his incredible team, proud to be a part of this incredible meeting @BeaumontCards @BeaumontIC @OUWB @crfheart
Two beautiful live cases this morning from @ErasmusMC at #JIMGISE2025 discussing hot topics in #TAVR ! #TaioredStrategy with @drnvanmieghem ! 🎯 @Drroxmehran @amrabbasmd @Dralkutshan @naifovino @BURZOTTA_F
@MrcTsl @AdamGreenbaumMD
@Marta33717088 @giuliamasiero3 @jimcongress
1
5
18
The largest medical #AI randomized controlled trial yet performed, enrolling >100,000 women undergoing mammography screening, was published today @LancetDigitalH The use of A.I. led to 29% higher detection of cancer, no increase of false positives, and reduced workload compared
0
0
1